Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Daiichi Sankyo is a global pharmaceutical company headquartered in Japan, dedicated to the research, development, manufacturing, and marketing of innovative medicines. The company focuses on therapeutic areas including oncology, cardiovascular diseases, and other specialties, aiming to provide advanced therapies to patients worldwide and contribute to the improvement of global health.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Daiichi Sankyo is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Daiichi Sankyo last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 37.72 JPY.
Across its last 4 earnings reports, Daiichi Sankyo stock moved by ±2.2% on average the following day. The largest reaction was -3.2% on 01/30/2026; 1 of 4 reactions were positive.
Daiichi Sankyo has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.